Dotinurad

dotinurad · Urica Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Dotinurad, covering 2025-01-28 to 2026-06-10. Get the full timeline:

Most recent: Clinical Trial Results: Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia [Phase 1, Phase 2]